Zura Bio Limited
ZURA
$1.21
-$0.05-3.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 35.24% | -51.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 22.39% | -18.57% | |||
| Operating Income | -22.39% | 18.57% | |||
| Income Before Tax | -28.01% | 34.19% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -28.01% | 34.19% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -28.01% | 34.19% | |||
| EBIT | -22.39% | 18.57% | |||
| EBITDA | -22.37% | 18.58% | |||
| EPS Basic | -88.54% | 62.12% | |||
| Normalized Basic EPS | -25.32% | 36.80% | |||
| EPS Diluted | -88.54% | 62.12% | |||
| Normalized Diluted EPS | -25.32% | 36.80% | |||
| Average Basic Shares Outstanding | 2.22% | 4.14% | |||
| Average Diluted Shares Outstanding | 2.22% | 4.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||